Position in DXCM
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$6,257,623
+$1,226,527 QoQ
Shares Held
92,912
+16.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#250
of 966 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $45,971,172 across 6 Medical Devices names. DXCM ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
56,413 | $17,761,068 | |
| 2 | BSX |
Boston Scientific Corp
|
243,100 | $10,375,508 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
110,498 | $7,072,976 | |
| 4 | DXCM |
Dexcom Inc
This page
|
92,912 | $6,257,623 | |
| 5 | ZBH |
Zimmer Biomet Holdings, Inc.
|
32,282 | $2,779,157 | |
| 6 | PODD |
Insulet Corp
|
11,329 | $1,724,840 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,257,623 | 92,912 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $5,031,096 | 80,113 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,808,440 | 72,449 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,180,939 | 17,550 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $3,413,339 | 49,983 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $2,129,525 | 31,765 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $2,641,187 | 23,295 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $1,951,786 | 14,072 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $118,630 | 956 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||